Skip to main content

WANETAM

WANETAM-4 · EU Global Health EDCTP3

Building West Africa's capacity to lead clinical research

A network of excellence strengthening clinical research, capacity building, and scientific leadership across TB, malaria, HIV/AIDS, and neglected tropical diseases in West Africa.

12 Countries

Anglophone, Francophone, and Lusophone, united across language barriers

23 Partner institutions

Research centres, universities, and hospitals working as one network

8 Work programmes

Covering TB, malaria, HIV/AIDS, NTDs, and cross-cutting capacity building

5 years (2026–2031)

 The current phase of a network built over three prior EDCTP funding cycles

WANETAM 4

A Network of Excellence for TB, AIDS and Malaria

From genome surveillance networks to a new generation of African research leaders, WANETAM builds the capacity that turns scientific ambition into public health impact.

01

WANETAM 4

2026-2031

Sub-Saharan Africa continues to face a heavy burden from poverty-related diseases . TB, malaria, HIV/AIDS, and neglected tropical diseases, while the research capacity to address them remains uneven across institutions, individuals, and funding levels. WANETAM-4, funded through the EU's Global Health EDCTP3 programme, builds on three previous tranches of funding to strengthen a network of clinical research sites across West Africa, train the next generation of African research leaders, and deepen ties with national public health institutions.

02

Our Vision

& Focus

To attain expertise in our network of West African institutions to conduct clinical trials, research and control of poverty-related diseases such as Malaria, Tuberculosis and HIV/AIDS.

03

Our Mission

and Objective

Building regional, national, institutional and individual capacities to conduct clinical trials in West Africa.

Over 15 Years Of Excellence

Welcome to WANETAM.

Since 2009, our network has worked to strengthen clinical research capacity across West Africa — building the institutions, training the scientists, and forging the partnerships needed to confront tuberculosis, malaria, HIV/AIDS, and other poverty-related diseases that continue to burden our region.

WANETAM-4 marks a new chapter in that journey. With support from the EU’s Global Health EDCTP3 programme, we now bring together 23 institutions across 12 countries — Anglophone, Francophone, and Lusophone alike — united by a shared commitment to research excellence and the next generation of African scientific leadership.

I invite you to explore our network, our work, and the people driving it forward.

Prof. Asan Jaye
WANETAM Coordinator

Work Programmes

Our Focus for Another 5 years

Programe 1

Characterising TB-associated multimorbidity, drug resistance, and vaccine trial platforms

Programe 2

Supporting national malaria control programmes, adaptive trials, and resistance surveillance

Programe 3

Early infant diagnosis, viral load monitoring, and long-acting antiretroviral research

Programe 4

Special Collaborative Training on Epidemic Preparedness and Surveillance

Programe 5

Building scientific leadership skills across the network

Programe 6

Strengthening trial oversight and pharmacovigilance capacity

Programe 7

Developing the next generation of African research leaders

Programe 8

Sharing network outputs and building visibility